Gene Variations May Predict Response to Breast Cancer Prevention Therapies

Researchers from the Mayo Clinic have identified variants in two genes that result in a higher chance that tamoxifen or raloxifene will actually prevent breast cancer. More studies are needed, but if confirmed, women with these variants may be more likely to undergo the 5-year preventive regimen.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news